N.B. Despite the fact that Medipure’s product IPR represents a new level of both quality, technical excellence and efficacy within the sterile storage market, Medipure recognises that is core skills and competencies do not lie in manufacturing and as such continues to offer such market leading IPR to other manufacturers therefore realizing the inherent market value within this IPR by pursuing a commercial strategy based on collaboration rather than competition via OEM/manufacturing royalty based licensing agreements.